Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease

Clinical and Laboratory Haematology

Volumn 24, Issue 2, 2002, Pages 81-88

  Wun, Ted ^a,b,c   Cordoba, Miguel ^a   Rangaswami, Arun ^a   Cheung, Anthony W ^a   Paglieroni, Teresa ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Monocyte; Platelet; Sickle cell

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD ANALYSIS; CAUCASIAN; CELL ACTIVATION; CELL AGGREGATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ETHNOLOGY; FEMALE; HUMAN; INFLAMMATION; KRUSKAL WALLIS TEST; MALE; MEDIATOR RELEASE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0036042517     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.t01-1-00433.x     Document Type: Article

References (48)

1. Neurologic complications
2. Stroke in a cohort of patients with homozygous sickle cell disease
3. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion
4. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease
5. Circulating cytokines in sickle cell patients during steady state
6. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anemia
7. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of disease show enhanced adhesion to vascular endothelium and increased expression of CD64
8. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease
9. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions
10. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
11. Platelet activation and interaction with leukocytes in patients with sepsis and multiorgan failure
12. Plasma endothelin-1, cytokine and prostoglandin E-2 levels in asymptomatic sickle cell disease and crisis
13. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
14. Perspective series: Cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium
15. The adhesive sickle erythrocyte: Cause and consequence of abnormal interactions with endothelium, monocyte/macrophages and model membranes
16. The endothelial biology of sickle cell disease
17. Mononuclear cells in sickle cell disease: Subpopulations and in vitro response to mitogens
18. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst
19. Platelet and leucocyte activation in childhood sickle cell disease: Association with nocturnal hypoxaemia
20. Detection of intracellular cytokines by flow cytometry
21. Adhesion of sickle neutrophils and erythrocytes to fibronectin
22. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
23. 1 integrin receptors on sickle reticulocytes and fibronectin
24. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation
25. Monocyte phagocytic activity in sickle cell disease
26. Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?
27. Prediction of adverse outcomes in children with sickle cell disease
28. Adhesion of sickle red blood cells and damage to interleukin-1β stimulated endothelial cells under flow in vitro
29. A global view on the role of monocytes and platelets in atherogenesis
30. Mortality in sickle cell disease. Life expectancy and risk factors for early death
31. Natural history of disease: The first two decades
32. Formation of platelet-leukocyte conjugates in whole blood
33. Cardiopulmonary bypass induces leukocyte-platelet adhesion
34. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion
35. Erythrophagocytosis in vivo in sickle cell anemia
36. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes
37. 1-integrin expression of sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium
38. Type 2 cytokine serum levels in healthy sickle cell disease patients
39. Interferon production in sickle cell disease
40. Platelet activation and procoagulant activity in sickle cell disease
41. Circulating platelets and red cells promote in vivo thrombogenic activity in sickle cell disease
42. Normal monocyte migratory response in patients with sickle cell disease
43. Reduced phagocytic activity mediated by C3b and Fc monocyte receptors from children with sickle-cell disease
44. Laboratory profile of sickle cell disease: A cross-sectional analysis. The Cooperative Study of Sickle Cell Disease
45. Activated platelets signal chemokine synthesis by human monocytes
46. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy
47. Platelet activation in patients with sickle cell disease
48. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia